These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 29719204)

  • 1. Drug-drug interactions in the treatment for alcohol use disorders: A comprehensive review.
    Guerzoni S; Pellesi L; Pini LA; Caputo F
    Pharmacol Res; 2018 Jul; 133():65-76. PubMed ID: 29719204
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Repurposing drugs for treatment of alcohol use disorder.
    Aubin HJ
    Int Rev Neurobiol; 2024; 175():153-185. PubMed ID: 38555115
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacotherapy of alcoholism - an update on approved and off-label medications.
    Soyka M; Müller CA
    Expert Opin Pharmacother; 2017 Aug; 18(12):1187-1199. PubMed ID: 28658981
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of precipitated opiate withdrawal syndrome induced by nalmefene mistakenly prescribed in opiate-dependent patients: a review for clinicians.
    Franchitto N; Jullian B; Salles J; Pelissier F; Rolland B
    Expert Opin Drug Metab Toxicol; 2017 Jun; 13(6):669-677. PubMed ID: 28343423
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Perspectives on the pharmacological management of alcohol use disorder: Are the approved medications effective?
    Antonelli M; Sestito L; Tarli C; Addolorato G
    Eur J Intern Med; 2022 Sep; 103():13-22. PubMed ID: 35597734
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selecting an appropriate alcohol pharmacotherapy: review of recent findings.
    Castrén S; Mäkelä N; Alho H
    Curr Opin Psychiatry; 2019 Jul; 32(4):266-274. PubMed ID: 30973369
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Medication Development for Alcohol Use Disorder: A Focus on Clinical Studies.
    Leggio L; Falk DE; Ryan ML; Fertig J; Litten RZ
    Handb Exp Pharmacol; 2020; 258():443-462. PubMed ID: 31628604
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological Treatment of Alcohol use Disorder in Patients with Psychotic Disorders: A Systematic Review.
    Rosenstand NJ; Nielsen AS; Skøt L; Anhøj S; Nielsen DG; Højlund M; Mellentin AI
    Curr Neuropharmacol; 2024; 22(6):1129-1143. PubMed ID: 36582063
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pharmacological therapies for alcohol use disorder in Japan].
    Yumoto Y; Higuchi S
    Nihon Rinsho; 2015 Sep; 73(9):1536-9. PubMed ID: 26394517
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel Agents for the Pharmacological Treatment of Alcohol Use Disorder.
    Burnette EM; Nieto SJ; Grodin EN; Meredith LR; Hurley B; Miotto K; Gillis AJ; Ray LA
    Drugs; 2022 Feb; 82(3):251-274. PubMed ID: 35133639
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety and Tolerability of Pharmacological Treatment of Alcohol Dependence: Comprehensive Review of Evidence.
    Sinclair JM; Chambers SE; Shiles CJ; Baldwin DS
    Drug Saf; 2016 Jul; 39(7):627-45. PubMed ID: 27023898
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological treatment of alcohol use disorder. Scientific evidence.
    Attilia F; Perciballi R; Rotondo C; Capriglione I; Iannuzzi S; Attilia ML; Vitali M; Alessandrini G; Scamporrino MCM; Fiore M; Ceccanti M;
    Riv Psichiatr; 2018; 53(3):123-127. PubMed ID: 29912214
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alcohol addiction - the safety of available approved treatment options.
    Antonelli M; Ferrulli A; Sestito L; Vassallo GA; Tarli C; Mosoni C; Rando MM; Mirijello A; Gasbarrini A; Addolorato G
    Expert Opin Drug Saf; 2018 Feb; 17(2):169-177. PubMed ID: 29120249
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological management of alcohol dependence: from mono-therapy to pharmacogenetics and beyond.
    Caputo F; Vignoli T; Grignaschi A; Cibin M; Addolorato G; Bernardi M
    Eur Neuropsychopharmacol; 2014 Feb; 24(2):181-91. PubMed ID: 24182622
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Opioid substitution therapy or hidden opioids are a minefield for nalmefene: an atypical case series of 11 patients in Lorraine.
    Yéléhé-Okouma M; Martini H; Lemarié J; Labroca P; Petitpain N; Gibaja V; Paille F; Gillet P
    Fundam Clin Pharmacol; 2017 Oct; 31(5):574-579. PubMed ID: 28322465
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Medical management of alcohol use disorders].
    Paille F
    Rev Prat; 2019 Oct; 69(8):909-916. PubMed ID: 32237660
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Baclofen for alcohol addiction].
    Helland A; Bramness JG
    Tidsskr Nor Laegeforen; 2011 Nov; 131(21):2132-3. PubMed ID: 22048211
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acamprosate. A review of its pharmacology and clinical potential in the management of alcohol dependence after detoxification.
    Wilde MI; Wagstaff AJ
    Drugs; 1997 Jun; 53(6):1038-53. PubMed ID: 9179530
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pharmacological Treatment for Alcohol Dependence].
    Matsushita S
    Brain Nerve; 2023 May; 75(5):613-622. PubMed ID: 37194540
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Are Alcohol Anti-relapsing and Alcohol Withdrawal Drugs Useful in Cannabinoid Users?
    Kleczkowska P; Smaga I; Filip M; Bujalska-Zadrozny M
    Neurotox Res; 2016 Nov; 30(4):698-714. PubMed ID: 27484692
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.